Ginkgolides protect against amyloid-β1–42-mediated synapse damage in vitro
Open Access
- 1 January 2008
- journal article
- Published by Springer Nature in Molecular Neurodegeneration
- Vol. 3 (1) , 1
Abstract
The early stages of Alzheimer's disease (AD) are closely associated with the production of the Aβ1–42 peptide, loss of synapses and gradual cognitive decline. Since some epidemiological studies showed that EGb 761, an extract from the leaves of the Ginkgo biloba tree, had a beneficial effect on mild forms of AD, the effects of some of the major components of the EGb 761 extract (ginkgolides A and B, myricetin and quercetin) on synapse damage in response to Aβ1–42 were examined.Keywords
This publication has 40 references indexed in Scilit:
- Squalestatin protects neurons and reduces the activation of cytoplasmic phospholipase A2 by Aβ1–42Neuropharmacology, 2007
- Quantitative determination of major active components in Ginkgo biloba dietary supplements by liquid chromatography/mass spectrometryRapid Communications in Mass Spectrometry, 2006
- Phospholipase A₂-Generated Lipid Mediators in the Brain: The Good, the Bad, and the UglyThe Neuroscientist, 2006
- Postsynaptically Synthesized Prostaglandin E2 (PGE2) Modulates Hippocampal Synaptic Transmission via a Presynaptic PGE2 EP2 ReceptorJournal of Neuroscience, 2005
- Activation of EP4 receptors contributes to prostaglandin E2-mediated stimulation of renal sensory nervesAmerican Journal of Physiology-Renal Physiology, 2004
- The role of platelet activating factor in prion and amyloid-β neurotoxicityNeuroReport, 2004
- Pharmacological Studies Supporting the Therapeutic Use of Ginkgo biloba Extract for Alzheimer’s DiseasePharmacopsychiatry, 2003
- Alzheimer's Disease Is a Synaptic FailureScience, 2002
- Influence of the Severity of Cognitive Impairment on the Effect of the Ginkgo biloba Extract EGb 761® in Alzheimer’s DiseaseNeuropsychobiology, 2002
- Enhancement of hippocampal excitatory synaptic transmission by platelet-activating factorNeuron, 1992